LA Biomed study finds medication improves health of patients with pulmonary arterial hypertension
Tuesday, November 17, 2009 - 10:44
in Health & Medicine
In one of the few studies of the long-term effects of medication in the treatment of pulmonary arterial hypertension (PAH) disease, a team of researchers found the health and exercise capacity of PAH patients improved after two years of treatment with ambrisentan, according to a study published in the current edition of the Journal of the American College of Cardiology.